诺泰生物
(688076)
| 流通市值：120.37亿 | | | 总市值：120.37亿 |
| 流通股本：2.25亿 | | | 总股本：2.25亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 724,666,310.21 | 571,391,578.32 | 561,512,124.49 | 555,215,624.54 |
| 应收票据及应收账款 | 554,018,361.01 | 535,665,461.88 | 559,359,774.58 | 489,135,468.67 |
| 其中：应收票据 | 4,253,029.12 | 3,980,476.04 | 1,863,007.91 | 1,295,220.1 |
| 应收账款 | 549,765,331.89 | 531,684,985.84 | 557,496,766.67 | 487,840,248.57 |
| 应收款项融资 | - | 3,544,808.89 | 1,595,761.65 | 1,300,000 |
| 预付款项 | 28,644,062.67 | 30,423,579.22 | 57,832,214.59 | 33,714,715.93 |
| 其他应收款合计 | 8,015,953.13 | 7,916,783.04 | 4,633,388.44 | 3,133,266.77 |
| 存货 | 621,517,183.7 | 584,040,572.4 | 521,105,440.8 | 436,045,081.46 |
| 其他流动资产 | 51,197,850.52 | 64,542,709.5 | 25,268,064.41 | 18,301,206.91 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,998,059,721.24 | 2,005,525,493.25 | 1,831,306,768.96 | 1,721,845,364.28 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 82,888,000 | 52,888,000 | 45,388,000 | 45,388,000 |
| 其他非流动金融资产 | 162,150,578.89 | 162,150,578.89 | 159,908,647.01 | 108,975,504.35 |
| 固定资产 | 1,518,809,399.51 | 1,516,535,046.87 | 1,332,929,513.58 | 1,324,368,445.52 |
| 在建工程 | 647,293,939.71 | 339,919,158.99 | 210,923,384.3 | 160,932,528.98 |
| 使用权资产 | 55,220,973.1 | 35,602,418.13 | 38,781,963.25 | 20,756,048.19 |
| 无形资产 | 106,053,343.01 | 108,193,280.07 | 105,542,076.45 | 108,167,477.81 |
| 开发支出 | 209,539,543.24 | 167,232,442.64 | 71,220,512.43 | 67,249,040.95 |
| 商誉 | 156,336,178.69 | 156,336,178.69 | 156,336,178.69 | 156,336,178.69 |
| 长期待摊费用 | 37,128,143.25 | 35,967,869.68 | 28,924,714.07 | 27,485,887.33 |
| 递延所得税资产 | 95,926,426.33 | 88,265,182.53 | 78,904,664.36 | 69,478,840.17 |
| 其他非流动资产 | 369,692,084.7 | 409,399,412.8 | 382,443,101.22 | 204,478,131.86 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,441,038,610.43 | 3,072,489,569.29 | 2,611,302,755.36 | 2,293,616,083.85 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 5,439,098,331.67 | 5,078,015,062.54 | 4,442,609,524.32 | 4,015,461,448.13 |
| 流动负债: | | | | |
| 短期借款 | 1,083,637,680.93 | 1,043,811,421.49 | 987,828,099.87 | 817,602,638.77 |
| 交易性金融负债 | - | - | 6,255.44 | - |
| 应付票据及应付账款 | 502,963,540.84 | 393,454,729.49 | 256,592,141.72 | 233,575,420.64 |
| 其中：应付票据 | 255,312,650.96 | 133,762,275.64 | 71,459,425.15 | 72,247,061.5 |
| 应付账款 | 247,650,889.88 | 259,692,453.85 | 185,132,716.57 | 161,328,359.14 |
| 合同负债 | 19,357,124.39 | 61,214,172.28 | 35,888,854.86 | 36,710,015.86 |
| 应付职工薪酬 | 44,919,389.13 | 75,015,093.92 | 46,833,705.47 | 38,516,988.76 |
| 应交税费 | 40,302,536.63 | 24,316,801.09 | 27,249,327.56 | 28,761,299.06 |
| 其他应付款合计 | 15,877,155.27 | 14,831,536.61 | 9,673,280.47 | 30,773,828.54 |
| 一年内到期的非流动负债 | 161,016,945.76 | 127,683,572.49 | 70,068,258.61 | 65,859,227.82 |
| 其他流动负债 | 13,543,142.63 | 12,382,862.91 | 2,551,125.96 | 1,833,569.91 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,881,617,515.58 | 1,752,710,190.28 | 1,436,691,049.96 | 1,253,632,989.36 |
| 非流动负债: | | | | |
| 长期借款 | 347,590,242.97 | 282,044,220.88 | 84,964,175.27 | - |
| 应付债券 | 166,228,671.48 | 163,166,991.61 | 160,594,856.45 | 248,859,577.63 |
| 租赁负债 | 43,368,458.28 | 25,746,738.36 | 31,496,318.51 | 15,976,722.5 |
| 长期应付款 | 95,640,427.44 | 107,428,687.27 | 52,746,800 | 39,306,800 |
| 递延收益 | 60,236,405.31 | 55,992,325.24 | 28,092,363.18 | 27,732,701.65 |
| 递延所得税负债 | 8,394,526.56 | 8,609,277.38 | 8,982,345.07 | 9,384,367.01 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 721,458,732.04 | 642,988,240.74 | 366,876,858.48 | 341,260,168.79 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,603,076,247.62 | 2,395,698,431.02 | 1,803,567,908.44 | 1,594,893,158.15 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 219,780,094 | 219,780,048 | 219,779,860 | 214,934,292 |
| 其他权益工具 | 69,834,031.2 | 69,834,692.18 | 69,837,336.07 | 116,379,829.76 |
| 资本公积 | 1,602,737,359.76 | 1,597,964,990.92 | 1,608,398,122.03 | 1,445,805,312.78 |
| 其他综合收益 | -24,745,200 | -24,745,200 | -24,745,200 | -24,745,200 |
| 专项储备 | 5,688,955.76 | 5,020,610.63 | 5,039,497.28 | 4,714,278.65 |
| 盈余公积 | 70,103,491.78 | 70,103,491.78 | 30,765,221.13 | 30,765,221.13 |
| 未分配利润 | 875,024,920.44 | 722,408,368.22 | 707,603,706.52 | 606,496,157.51 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,818,423,652.94 | 2,660,367,001.73 | 2,616,678,543.03 | 2,394,349,891.83 |
| 少数股东权益 | 17,598,431.11 | 21,949,629.79 | 22,363,072.85 | 26,218,398.15 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,836,022,084.05 | 2,682,316,631.52 | 2,639,041,615.88 | 2,420,568,289.98 |
| 负债和股东权益合计 | 5,439,098,331.67 | 5,078,015,062.54 | 4,442,609,524.32 | 4,015,461,448.13 |
| 公告日期 | 2025-04-23 | 2025-04-23 | 2024-10-23 | 2024-08-23 |
| 审计意见(境内) | | 带强调事项段的无保留意见 | | |